Clinical Study of Meplazumab to Treat With Malaria

Stopped The same drug has completed the phase I and II clinical trials for COVID-19

Conditions

• Malaria (Plasmodium Falciparum)

Interventions

• DRUG: Meplazumab for Injection
• DRUG: Sterile normal saline (0.9%)

Sponsor

Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd